Dexamethasone palmitate-loaded nanodiscs target inflamed joints and suppress rheumatoid arthritis.
These studies demonstrate that DXP-NDs traffic to inflamed arthritic joints and lymphatic tissues after subcutaneous administration and promote coordinated anti-inflammatory and immunoregulatory effects that attenuate joint inflammation and limit disease progression in murine arthritis models.